These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

341 related items for PubMed ID: 17145810

  • 1. Implication of polycomb members Bmi-1, Mel-18, and Hpc-2 in the regulation of p16INK4a, p14ARF, h-TERT, and c-Myc expression in primary breast carcinomas.
    Silva J, García JM, Peña C, García V, Domínguez G, Suárez D, Camacho FI, Espinosa R, Provencio M, España P, Bonilla F.
    Clin Cancer Res; 2006 Dec 01; 12(23):6929-36. PubMed ID: 17145810
    [Abstract] [Full Text] [Related]

  • 2. The Bmi-1 oncogene induces telomerase activity and immortalizes human mammary epithelial cells.
    Dimri GP, Martinez JL, Jacobs JJ, Keblusek P, Itahana K, Van Lohuizen M, Campisi J, Wazer DE, Band V.
    Cancer Res; 2002 Aug 15; 62(16):4736-45. PubMed ID: 12183433
    [Abstract] [Full Text] [Related]

  • 3. Mel-18 acts as a tumor suppressor by repressing Bmi-1 expression and down-regulating Akt activity in breast cancer cells.
    Guo WJ, Zeng MS, Yadav A, Song LB, Guo BH, Band V, Dimri GP.
    Cancer Res; 2007 Jun 01; 67(11):5083-9. PubMed ID: 17545584
    [Abstract] [Full Text] [Related]

  • 4. Mel-18 negatively regulates INK4a/ARF-independent cell cycle progression via Akt inactivation in breast cancer.
    Lee JY, Jang KS, Shin DH, Oh MY, Kim HJ, Kim Y, Kong G.
    Cancer Res; 2008 Jun 01; 68(11):4201-9. PubMed ID: 18519679
    [Abstract] [Full Text] [Related]

  • 5. p16Ink4a suppression of lung adenocarcinoma by Bmi-1 in the presence of p38 activation.
    Lee MO, Lee HJ, Kim MA, Kim EK, Lee JH, Heo JH, Lee SH, Cho SH, Fornace AJ, Jeong HC, Cha HJ.
    J Thorac Oncol; 2011 Mar 01; 6(3):423-31. PubMed ID: 21164364
    [Abstract] [Full Text] [Related]

  • 6. Mel-18, a polycomb group protein, regulates cell proliferation and senescence via transcriptional repression of Bmi-1 and c-Myc oncoproteins.
    Guo WJ, Datta S, Band V, Dimri GP.
    Mol Biol Cell; 2007 Feb 01; 18(2):536-46. PubMed ID: 17151361
    [Abstract] [Full Text] [Related]

  • 7. BMI-1 gene amplification and overexpression in hematological malignancies occur mainly in mantle cell lymphomas.
    Beà S, Tort F, Pinyol M, Puig X, Hernández L, Hernández S, Fernandez PL, van Lohuizen M, Colomer D, Campo E.
    Cancer Res; 2001 Mar 15; 61(6):2409-12. PubMed ID: 11289106
    [Abstract] [Full Text] [Related]

  • 8. USP22 acts as an oncogene by the activation of BMI-1-mediated INK4a/ARF pathway and Akt pathway.
    Liu YL, Jiang SX, Yang YM, Xu H, Liu JL, Wang XS.
    Cell Biochem Biophys; 2012 Jan 15; 62(1):229-35. PubMed ID: 21928107
    [Abstract] [Full Text] [Related]

  • 9. The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression.
    Vonlanthen S, Heighway J, Altermatt HJ, Gugger M, Kappeler A, Borner MM, van Lohuizen M, Betticher DC.
    Br J Cancer; 2001 May 18; 84(10):1372-6. PubMed ID: 11355949
    [Abstract] [Full Text] [Related]

  • 10. Id1 enhances RING1b E3 ubiquitin ligase activity through the Mel-18/Bmi-1 polycomb group complex.
    Qian T, Lee JY, Park JH, Kim HJ, Kong G.
    Oncogene; 2010 Oct 28; 29(43):5818-27. PubMed ID: 20697353
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The Bmi-1 oncoprotein is overexpressed in human colorectal cancer and correlates with the reduced p16INK4a/p14ARF proteins.
    Kim JH, Yoon SY, Kim CN, Joo JH, Moon SK, Choe IS, Choe YK, Kim JW.
    Cancer Lett; 2004 Jan 20; 203(2):217-24. PubMed ID: 14732230
    [Abstract] [Full Text] [Related]

  • 13. Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells.
    Song LB, Zeng MS, Liao WT, Zhang L, Mo HY, Liu WL, Shao JY, Wu QL, Li MZ, Xia YF, Fu LW, Huang WL, Dimri GP, Band V, Zeng YX.
    Cancer Res; 2006 Jun 15; 66(12):6225-32. PubMed ID: 16778197
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Alterations of INK4a(p16-p14ARF)/INK4b(p15) expression and telomerase activation in meningioma progression.
    Simon M, Park TW, Köster G, Mahlberg R, Hackenbroch M, Boström J, Löning T, Schramm J.
    J Neurooncol; 2001 Dec 15; 55(3):149-58. PubMed ID: 11859969
    [Abstract] [Full Text] [Related]

  • 17. p14ARF homozygous deletion or MDM2 overexpression in Burkitt lymphoma lines carrying wild type p53.
    Lindström MS, Klangby U, Wiman KG.
    Oncogene; 2001 Apr 19; 20(17):2171-7. PubMed ID: 11360201
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. P16(INK4A) is implicated in both the immediate and adaptative response of human keratinocytes to UVB irradiation.
    Chazal M, Marionnet C, Michel L, Mollier K, Dazard JE, Della Valle V, Larsen CJ, Gras MP, Basset-Séguin N.
    Oncogene; 2002 Apr 18; 21(17):2652-61. PubMed ID: 11965538
    [Abstract] [Full Text] [Related]

  • 20. CBX7 controls the growth of normal and tumor-derived prostate cells by repressing the Ink4a/Arf locus.
    Bernard D, Martinez-Leal JF, Rizzo S, Martinez D, Hudson D, Visakorpi T, Peters G, Carnero A, Beach D, Gil J.
    Oncogene; 2005 Aug 25; 24(36):5543-51. PubMed ID: 15897876
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.